Abstract: Automatic generation of document templates based on recognized composition element patterns in a group of clustered documents is provided. Composition elements used in documents are typically unique to a particular user or to a group of users. An automated template generation system detects composition element patterns in documents associated with a given user. Sequences of composition elements from one document are aligned with sequences of composition elements of one or more other documents. The aligned sequences are scored to generate a document distance matrix. The documents are clustered together based on the alignment scores and a document template is generated for each corresponding cluster of documents. In one or more aspects, selecting a document template and updating it results in a modified document template or, in certain cases, a new document template. The generated document templates are displayed in a user interface for selection by a user.

Abstract: Automatic generation of document templates based on recognized composition element patterns in a group of clustered documents is provided. Composition elements used in documents are typically unique to a particular user or to a group of users. An automated template generation system detects composition element patterns in documents associated with a given user. Sequences of composition elements from one document are aligned with sequences of composition elements of one or more other documents. The aligned sequences are scored to generate a document distance matrix. The documents are clustered together based on the alignment scores and a document template is generated for each corresponding cluster of documents. In one or more aspects, selecting a document template and updating it results in a modified document template or, in certain cases, a new document template. The generated document templates are displayed in a user interface for selection by a user.

Abstract: The present disclosure provides a method for cancer relapse prediction that provides higher resolution grading than Gleason score alone. In particular, the method provides for prediction of prostate cancer relapse that correlates gene expression of each individual signature gene and deriving a prostate cancer gene expression (GEX) score in the plurality of prostate cancer tissue samples; and correlating said GEX score with the clinical outcome for each prostate carcinoma tissue sample. A set of signature genes is provided that encompasses all or a sub-combination of GI_2094528, KIP2, NRG1, NBL1, Prostein, CCNE2, CDC6, FBP1, HOXC6, MKI67, MYBL2, PTTG1, RAMP, UBE2C, Wnt5A, MEMD, AZGP1, CCK, MLCK, PPAP2B, and PROK1.

Abstract: The present disclosure provides a method for cancer relapse prediction that provides higher resolution grading than Gleason score alone. In particular, the method provides for prediction of prostate cancer relapse that correlates gene expression of each individual signature gene and deriving a prostate cancer gene expression (GEX) score in the plurality of prostate cancer tissue samples; and correlating said GEX score with the clinical outcome for each prostate carcinoma tissue sample. A set of signature genes is provided that encompasses all or a sub-combination of GI_2094528, KIP2, NRG1, NBL1, Prostein, CCNE2, CDC6, FBP1, HOXC6, MKI67, MYBL2, PTTG1, RAMP, UBE2C, Wnt5A, MEMD, AZGP1, CCK, MLCK, PPAP2B, and PROK1.

Abstract: The present invention provides a method for preparing a reference model for cancer relapse prediction that provides higher resolution grading than Gleason score alone.

Abstract: The present invention provides a method for preparing a reference model for cancer relapse prediction that provides higher resolution grading than Gleason score alone.

Abstract: The present invention provides a method for preparing a reference model for cancer relapse prediction that provides higher resolution grading than Gleason score alone.

Abstract: The present embodiments relate to a system and method of measuring the methylation level of DNA. Some embodiments relate to a system and method of measuring methylation level of DNA with a gene array.

Abstract: The present embodiments relate to a system and method of measuring the methylation level of DNA. Some embodiments relate to a system and method of measuring methylation level of DNA with a gene array.